{"title":"非贝特类药物：过去的历史还是复兴？","authors":"Robert Elkeles","doi":"10.15277/bjd.2023.415","DOIUrl":null,"url":null,"abstract":"Fibrates have been in use to modify serum lipids since the 1960s. This review seeks to ascertain their present place in lipid-modifying therapy and prevention of cardiovascular disease, particularly in type 2 diabetes (T2DM).","PeriodicalId":42951,"journal":{"name":"British Journal of Diabetes","volume":" 4","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fibrates: past history or renaissance?\",\"authors\":\"Robert Elkeles\",\"doi\":\"10.15277/bjd.2023.415\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Fibrates have been in use to modify serum lipids since the 1960s. This review seeks to ascertain their present place in lipid-modifying therapy and prevention of cardiovascular disease, particularly in type 2 diabetes (T2DM).\",\"PeriodicalId\":42951,\"journal\":{\"name\":\"British Journal of Diabetes\",\"volume\":\" 4\",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15277/bjd.2023.415\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15277/bjd.2023.415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Fibrates have been in use to modify serum lipids since the 1960s. This review seeks to ascertain their present place in lipid-modifying therapy and prevention of cardiovascular disease, particularly in type 2 diabetes (T2DM).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
